RNA Vaccines and Therapeutics: Challenges and Opportunities
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: 20 July 2024 | Viewed by 98
Special Issue Editor
Interests: RNA-based therapeutics and diagnostics; gene therapy; cancer; genetic disease; immune disorder; virus, microRNAs; ribozyme; aptamer; genome editing
Special Issue Information
Dear Colleagues,
Advances in RNA-based technologies such as RNA interference and RNA/genome editing have initiated a new era in the field of therapeutics, with potential to overcome the limitation of existing treatments through their features, including the specificity, efficacy, flexibility and targetability of non-druggable targets, etc. Moreover, the success of messenger RNA as a vaccine against SARS-CoV-2 has further spurred and expanded medical uses of RNA. This Special Issue aims to provide an overview of the current status and future trends of the cutting-edge RNA-based technologies in the medical field. We welcome contributions, including original articles, reviews and perspectives, on RNA-based therapeutics and vaccinology, from basic research to clinical applications.
Prof. Dr. Seong-Wook Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- RNA-based therapy
- RNA vaccine
- mRNA
- circRNA
- saRNA
- non-coding RNA/sRNA
- microRNA/siRNA/antisense RNA
- RNA aptamer
- ribozyme
- RNA editing/genome editing
